Germline mutations in the BAP1 gene have also been associated with BAP1-tumor predisposition syndrome which carries an increased risk of developing uveal melanoma, cutaneous melanoma, malignant mesothelioma, RCC, meningioma, and cholangiocarcinoma. This evidence concerns the gene BAP1 and malignant mesothelioma.